[Medical treatment of idiopathic calcium lithiasis (II)].
Bataille
P
P
Finet
M
M
Renaud
H
H
Fievet
P
P
Rogez
J C
JC
Fournier
A
A
D000493:Allopurinol / Q000627:therapeutic use; D001581:Benzothiadiazines; D002118:Calcium / Q000378:metabolism*; D002482:Cellulose / Q000031:analogs & derivatives / Q000627:therapeutic use; D002951:Citrates / Q000627:therapeutic use; D019343:Citric Acid; D004232:Diuretics; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D010426:Pentosan Sulfuric Polyester / Q000627:therapeutic use; D010758:Phosphorus / Q000627:therapeutic use; D010833:Phytic Acid / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013388:Succinimides / Q000627:therapeutic use; D014545:Urinary Calculi / Q000188:drug therapy*
D001581:Benzothiadiazines; D002951:Citrates; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D013388:Succinimides; D010758:Phosphorus; D019343:Citric Acid; D010426:Pentosan Sulfuric Polyester; D000493:Allopurinol; D010833:Phytic Acid; D002482:Cellulose; C008881:phosphocellulose; D008274:Magnesium; D011736:Pyridoxine; D002118:Calcium
Traitement médical de la lithiase calcique idiopathique (II).